Disease and Therapy Review Hepatitis C

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Sarepta Therapeutics Incorporated

Sarepta Therapeutics Incorporated

  • $ 55
  • Company report
  • by Wright Investors' Service
  • July 2014
  • 56 pages

A textual analysis of the financial results for Sarepta Therapeutics Incorporated compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A ...

Industries: Therapy | Countries: China

Town Health International Investments Limited (3886) - Financial and Strategic SWOT Analysis Review

Town Health International Investments Limited (3886) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • June 2014
  • 25 pages

Summary Town Health International Investments Limited (THIIL) is an investment holding company. The company provides medical, dental, and healthcare related services. It offers services that include outpatient services, specialist clinical services, dental services, physiotherapy services, paramedical ...

Industries: Therapy | Countries: China

Global Proton Therapy Outlook 2018

Global Proton Therapy Outlook 2018

  • $ 2 000
  • Industry report
  • by RNCOS
  • June 2014
  • 90 pages

Proton Therapy, the new kid on the block for cancer treatment, has garnered worldwide attention in the past few years. Due to its ability to deliver higher doses of radiation to the targeted areas without affecting the healthy tissues, it is being promulgated as the next big thing in the world of cance ...

Industries: Therapy | Countries: Germany, China, Japan, World

Vectura Group plc (VEC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Vectura Group plc (VEC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • May 2014
  • 23 pages

Summary Vectura Group plc (Vectura) is a product development company, which develops inhaled pharmaceuticals using a range of proprietary lung delivery technologies, including device and formulation capabilities. It undertakes the development, manufacture and marketing of pharmaceutical therapies fo ...

Industries: Therapy | Countries: China

Health Care Markets in China

Health Care Markets in China

  • $ 4 000
  • Industry report
  • by Asia Market Information & Development Company
  • May 2014
  • 228 pages

China's demand for Health Care has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, ...

Industries: Therapy | Countries: China

Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 - Novel HER-2 Positive Therapies Provide Diversified Treatment Options

Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 - Novel HER-2 Positive Therapies Provide Diversified Treatment Options

  • $ 3 500
  • Industry report
  • by GBI Research
  • May 2014
  • 103 pages

Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 - Novel HER-2 Positive Therapies Provide Diversified Treatment Options Summary GBI Research, the leading business intelligence provider, has released its latest research: "Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 - Novel HER-2 ...

Industries: Therapy | Countries: World, Australia, Japan, China, India

Harbor Therapeutics, Inc. (HRBR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Harbor Therapeutics, Inc. (HRBR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • April 2014
  • 18 pages

Summary Harbor Therapeutics, Inc. (Harbor) formerly known as Harbor BioSciences, Inc. is a development-stage pharmaceutical company. It focuses on the development of products for the treatment of diseases related to aging which are adrenal steroid hormones and hormone analogs, derived from the human ...

Industries: Therapy | Countries: China, United States

Pain Therapeutics, Inc., Wright Investors' Service

Pain Therapeutics, Inc., Wright Investors' Service

  • $ 55
  • Company report
  • by Wright Investors' Service
  • April 2014
  • 42 pages

A textual analysis of the financial results for Pain Therapeutics, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description ...

Industries: Therapy | Countries: China

Epilepsy Therapeutics in Asia Pacific Markets to 2019 - Treatment Options Enhanced As Novel Next Generation AEDs Show Improved Safety and Tolerability

Epilepsy Therapeutics in Asia Pacific Markets to 2019 - Treatment Options Enhanced As Novel Next Generation AEDs Show Improved Safety and Tolerability

  • $ 3 500
  • Industry report
  • by GBI Research
  • March 2014
  • 66 pages

Epilepsy Therapeutics in Asia Pacific Markets to 2019 - Treatment Options Enhanced As Novel Next Generation AEDs Show Improved Safety and Tolerability Summary GBI Research, the leading business intelligence provider, has released its latest research, "Epilepsy Therapeutics in Asia Pacific Markets to ...

Industries: Therapy | Countries: World, China, Australia, India, Japan, Asia

Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 - Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need

Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 - Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need

  • $ 3 500
  • Industry report
  • by GBI Research
  • January 2014
  • 86 pages

Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 - Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need Summary GBI Research, the leading business intelligence provider, has released its latest research, "Gastrointestinal Therapeutics in Asia-Pacific Markets to ...

Industries: Therapy | Countries: World, Australia, Japan, India, China

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.